Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Myelodysplastic Syndromes 40Multiple Myeloma 34Lymphoma 32Leukemia 28Lymphoma, Non-Hodgkin 27Leukemia, Lymphocytic, Chronic, B-Cell 24Hodgkin Disease 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Hematologic Neoplasms 17Lymphoma, Large B-Cell, Diffuse 16Primary Myelofibrosis 11Neoplasms, Plasma Cell 10Leukemia, Myelomonocytic, Chronic 10Lymphoma, Follicular 9Graft vs Host Disease 9Myeloproliferative Disorders 8Neuroblastoma 7Leukemia, Myelomonocytic, Juvenile 7Lymphoma, Mantle-Cell 6Breast Neoplasms 6Recurrence 5Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Biphenotypic, Acute 5Wilms Tumor 4Rhabdoid Tumor 4Polycythemia Vera 4Lymphoma, T-Cell 4

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non-Malignant Neoplasm × Stem Cell Transplantation × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡